,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af,clinvar_classification,clinvar_condition,clinvar_review_status,clinvar_variant_id
0,1,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,2,P,R,,,,,,,,,,,,,ClinVar,,,"hg19,16:87426038-87426038, hg38,16:87392432-87392432","hg19,16:g.87426038C>G, hg38,16:g.87392432C>G",0.145,,,0.0000000000000000,,,,Uncertain significance,not specified,1,2358122
2,2,P,S,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87426037-87426037","hg19,16:g.87426037C>T",0.055,,,0.0000405975966223,,,,,,,
3,3,S,L,,,,,,,,,,,,,COSMIC,,,"hg38,16:87392435-87392435","hg38,16:g.87392435C>T",0.227,"eye, urinary_tract, bladder","carcinoma, small_cell_carcinoma, retinoblastoma",0.0012579161967554,,,,,,,
4,3,S,W,,,,,,,,,,,,,COSMIC,,,"hg38,16:87392435-87392435","hg38,16:g.87392435C>G",0.158,oesophagus,"carcinoma, squamous_cell_carcinoma",0.0000216882102889,0.0000321957501610,,,,,,
5,4,E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6,5,K,,,,Ubq,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,
7,6,T,,P,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,
8,7,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,
9,8,K,N,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,COSMIC,,,"hg38,16:87392451-87392451","hg38,16:g.87392451G>T",0.159,"skin, back","adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma",0.0000000000000000,,,,,,,
10,9,Q,H,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,16:87426060-87426060","hg19,16:g.87426060G>C",0.156,,,,,,,,,,
11,10,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,
12,11,R,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,"cBioPortal,ClinVar",lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,16:87426065-87426065, hg38,16:87392459-87392459","hg19,16:g.87426065G>T, hg38,16:g.87392459G>T",0.226,,,0.0000000000000000,,,,Uncertain significance,not specified,1,2226367
13,12,T,S,P,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,COSMIC,,,"hg38,16:87392461-87392461","hg38,16:g.87392461A>T",0.097,"haematopoietic_and_lymphoid_tissue, abdomen","lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant",,,,,,,,
14,13,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,
15,14,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,
16,15,Q,R,,,,,,,,,,,,,ClinVar,,,"hg19,16:87432424-87432424, hg38,16:87398818-87398818","hg19,16:g.87432424A>G, hg38,16:g.87398818A>G",0.193,,,0.0000079532982328,,,,Uncertain significance,not specified,1,3542641
17,16,R,G,,,,,,,,,,,,,COSMIC,,,"hg38,16:87398820-87398820","hg38,16:g.87398820A>G",0.762,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,,,,
18,17,V,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
19,18,E,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,
20,19,D,Y,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,cBioPortal,mixed_pipseq_2017,Mixed Cancer Types,"hg19,16:87432435-87432435","hg19,16:g.87432435G>T",0.524,,,,,,,,,,
21,20,V,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,
22,21,R,G,,Me,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,cBioPortal,skcm_tcga,Cutaneous Melanoma,"hg19,16:87432441-87432441","hg19,16:g.87432441C>G",0.125,,,,,,,,,,
23,21,R,Q,,Me,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, pancan_pdmr_2025, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014","Colon Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,16:87398836-87398836, hg19,16:87432442-87432442, hg38,16:87398836-87398836","hg19,16:g.87398836G>A, hg19,16:g.87432442G>A, hg38,16:g.87398836G>A",0.066,endometrium,"carcinoma, endometrioid_carcinoma",0.0000079526657336,,,,,,,
24,22,L,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,
25,23,I,F,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,"cBioPortal,COSMIC",nsclc_mskcc_2018,Non-Small Cell Lung Cancer,"hg19,16:87432447-87432447, hg38,16:87398841-87398841","hg19,16:g.87432447A>T, hg38,16:g.87398841A>T",0.632,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,
26,24,R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
27,25,E,Q,,,,,,,,,,,,,"cBioPortal,ClinVar",prad_msk_mdanderson_2023,Prostate,"hg19,16:87432453-87432453, hg38,16:87398847-87398847","hg19,16:g.87432453G>C, hg38,16:g.87398847G>C",0.061,,,0.0060480984873789,0.0070709644540706,,,Benign,not provided,1,781343
28,26,Q,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
29,27,H,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
30,28,P,L,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:87398857-87398857, hg19,16:87432463-87432463, hg38,16:87398857-87398857","hg19,16:g.87398857C>T, hg19,16:g.87432463C>T, hg38,16:g.87398857C>T",0.411,skin,malignant_melanoma,,,,,,,,
31,29,T,A,P,,,,,,,,,,,,"cBioPortal,COSMIC",gbc_shanghai_2014,Gallbladder Cancer,"hg19,16:87432465-87432465, hg38,16:87398859-87398859","hg19,16:g.87432465A>G, hg38,16:g.87398859A>G",0.147,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,0.0000955170657157,,,,,,
32,29,T,I,P,,,,,,,,,,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>T, hg38,16:g.87398860C>T",0.168,,,0.0000079527922254,,,,Uncertain significance,not specified,1,2493543
33,29,T,N,P,,,,,,,,,,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>A, hg38,16:g.87398860C>A",0.067,,,0.0000278347727887,0.0000636739891754,,,Uncertain significance,not specified,1,4051121
34,30,K,,,,Ubq,,,,,,,,,,,,,,,,,,,,,,,,,
35,31,I,N,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,16:87432472-87432472","hg19,16:g.87432472T>A",0.716,,,,,,,,,,
36,32,P,L,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,16:87432474-87432475, hg38,16:87398868-87398869","hg19,16:g.87432474_87432475delinsTT, hg38,16:g.87398868_87398869delinsTT",,skin,"carcinoma, basal_cell_carcinoma",,,,,,,,
37,32,P,Q,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,16:87432475-87432475","hg19,16:g.87432475C>A",0.755,,,,,,,,,,
38,32,P,S,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,COSMIC,,,"hg38,16:87398868-87398868","hg38,16:g.87398868C>T",0.812,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,
39,33,V,A,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,16:87435782-87435782","hg19,16:g.87435782T>C",0.630,,,0.0001591330431808,0.0003186946268086,,,,,,
40,34,I,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,,,,,,,,,,,,,,,,
41,35,I,V,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,"cBioPortal,COSMIC",mm_broad,Plasma Cell Myeloma,"hg19,16:87435787-87435787, hg38,16:87402181-87402181","hg19,16:g.87435787A>G, hg38,16:g.87402181A>G",0.284,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",,,,,,,,
42,36,E,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,,,,,,,,,,,,,,,,
43,37,R,Q,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:87402188-87402188, hg19,16:87435794-87435794, hg38,16:87402188-87402188","hg19,16:g.87402188G>A, hg19,16:g.87435794G>A, hg38,16:g.87402188G>A",0.514,lung,"carcinoma, adenocarcinoma",0.0000039783893888,,,,,,,
44,38,Y,H,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:87402190-87402190, hg19,16:87435796-87435796, hg38,16:87402190-87402190","hg19,16:g.87402190T>C, hg19,16:g.87435796T>C, hg38,16:g.87402190T>C",0.363,endometrium,"carcinoma, endometrioid_carcinoma",0.0000039770919504,,,,,,,
45,39,K,R,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,"cBioPortal,COSMIC","coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018","Colon Adenocarcinoma, Colorectal Adenocarcinoma","hg19,16:87402194-87402194, hg19,16:87435800-87435800, hg38,16:87402194-87402194","hg19,16:g.87402194A>G, hg19,16:g.87435800A>G, hg38,16:g.87402194A>G",0.065,"large_intestine, caecum","carcinoma, adenocarcinoma",,,,,,,,
46,40,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,
47,41,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,
48,42,K,,,,Ubq,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,
49,43,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,
50,44,L,F,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,ClinVar,,,"hg19,16:87435814-87435814, hg38,16:87402208-87402208","hg19,16:g.87435814C>T, hg38,16:g.87402208C>T",0.359,,,,,,,Uncertain significance,not specified,1,2298840
51,44,L,P,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,ClinVar,,,"hg19,16:87435815-87435815, hg38,16:87402209-87402209","hg19,16:g.87435815T>C, hg38,16:g.87402209T>C",0.632,,,,,,,Uncertain significance,not specified,1,2298841
52,45,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,
53,46,V,F,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,cBioPortal,hgsoc_tcga_gdc,High-Grade Serous Ovarian Cancer,"hg19,16:87402214-87402214","hg19,16:g.87402214G>T",,,,,,,,,,,
54,47,L,M,,,,,,,,,,,,,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,16:87435823-87435823","hg19,16:g.87435823C>A",0.340,,,,,,,,,,
55,48,D,Y,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,cBioPortal,cscc_ranson_2022,Cutaneous Squamous Cell Carcinoma,"hg19,16:87402220-87402220","hg19,16:g.87402220G>T",,,,,,,,,,,
56,49,K,N,,,Ubq,,,Ac,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,"cBioPortal,COSMIC","mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:87435831-87435831, hg38,16:87402225-87402225","hg19,16:g.87435831A>C, hg38,16:g.87402225A>C",0.495,skin,malignant_melanoma,,,,,,,,
57,50,T,I,P,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,COSMIC,,,"hg38,16:87402227-87402227","hg38,16:g.87402227C>T",0.502,"upper_aerodigestive_tract, mouth, gingiva","carcinoma, squamous_cell_carcinoma",,,,,,,,
58,50,T,R,P,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,ClinVar,,,"hg19,16:87435833-87435833, hg38,16:87402227-87402227","hg19,16:g.87435833C>G, hg38,16:g.87402227C>G",0.415,,,0.0000039767440011,,,,Uncertain significance,not specified,1,3870023
59,51,K,,,,Ubq,,,Ac,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,
60,52,F,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,
61,53,L,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,
62,54,V,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 54-58, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,
63,55,P,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 54-58, ELM",,,,,,,,,,,,,,,,,
64,56,D,G,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 54-58, ELM",,ClinVar,,,"hg19,16:87435851-87435851, hg38,16:87402245-87402245","hg19,16:g.87435851A>G, hg38,16:g.87402245A>G",0.408,,,,,,,Uncertain significance,not specified,1,2291996
65,56,D,N,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 54-58, ELM",,"cBioPortal,COSMIC","prad_fhcrc, prad_p1000, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Prostate Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:87402244-87402244, hg19,16:87435850-87435850, hg38,16:87402244-87402244","hg19,16:g.87402244G>A, hg19,16:g.87435850G>A, hg38,16:g.87402244G>A",0.341,"prostate, stomach","carcinoma, adenocarcinoma",,,,,,,,
66,57,H,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 54-58, ELM",,,,,,,,,,,,,,,,,
67,58,V,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 54-58, ELM",,,,,,,,,,,,,,,,,
68,59,N,K,,,,,,,,,,,,,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,16:87435861-87435861","hg19,16:g.87435861C>A",0.281,,,,,,,,,,
69,60,M,I,,,,,,,,,,,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,16:87402258-87402258, hg19,16:87435864-87435864, hg38,16:87402258-87402258","hg19,16:g.87402258G>A, hg19,16:g.87435864G>A, hg38,16:g.87402258G>A",0.261,"urinary_tract, bladder",carcinoma,,,,,,,,
70,60,M,V,,,,,,,,,,,,,COSMIC,,,"hg38,16:87402256-87402256","hg38,16:g.87402256A>G",0.277,liver,carcinoma,0.0000994502390784,0.0004138545778683,,,,,,
71,61,S,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
72,62,E,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
73,63,L,F,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,COSMIC,,,"hg38,16:87402265-87402265","hg38,16:g.87402265C>T",0.293,"skin, head_neck","malignant_melanoma, nodular",,,,,,,,
74,64,I,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
75,65,K,E,,,Ubq,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:87435877-87435877, hg38,16:87402271-87402271","hg19,16:g.87435877A>G, hg38,16:g.87402271A>G",0.314,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000278640235650,,,,,,,
76,66,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
77,67,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
78,68,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 68-70, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
79,69,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 69-71, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 68-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 69-71, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
80,70,R,C,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 69-71, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 68-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 69-71, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,"cBioPortal,COSMIC","ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018",Endometrial Carcinoma,"hg19,16:87402927-87402927, hg19,16:87436533-87436533, hg38,16:87402927-87402927","hg19,16:g.87402927C>T, hg19,16:g.87436533C>T, hg38,16:g.87402927C>T",0.467,endometrium,"carcinoma, endometrioid_carcinoma",,,,,,,,
81,70,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 69-71, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 68-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 69-71, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436534-87436534, hg38,16:87402928-87402928","hg19,16:g.87436534G>A, hg38,16:g.87402928G>A",0.513,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma",0.0000079738457858,,,,,,,
82,71,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 69-71, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 69-71, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
83,72,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
84,73,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
85,74,N,S,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,cBioPortal,"gbm_mayo_pdx_sarkaria_2019, pancan_pdmr_2025","Glioblastoma Multiforme, Mixed Cancer Types","hg19,16:87436546-87436546","hg19,16:g.87436546A>G",0.145,,,0.0000796400270776,0.0000318410494810,,,,,,
86,75,A,D,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436549-87436549","hg19,16:g.87436549C>A",0.206,,,,,,,,,,
87,76,N,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,
88,77,Q,R,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,ClinVar,,,"hg19,16:87436555-87436555, hg38,16:87402949-87402949","hg19,16:g.87436555A>G, hg38,16:g.87402949A>G",0.403,,,,,,,Uncertain significance,not specified,1,3292933
89,78,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
90,79,F,L,,,,,,,,,,,,,ClinVar,,,"hg19,16:87436562-87436562, hg38,16:87402956-87402956","hg19,16:g.87436562C>A, hg38,16:g.87402956C>A",0.291,,,,0.0000318430773150,,,Uncertain significance,not specified,1,3542642
91,80,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
92,81,L,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
93,82,L,F,,,,,,,,,,,,,COSMIC,,,"hg38,16:87402965-87402965","hg38,16:g.87402965G>T",0.295,liver,"other, neoplasm",,,,,,,,
94,83,V,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
95,84,N,K,,,,,,,,,,,,,ClinVar,,,"hg19,16:87436577-87436577, hg38,16:87402971-87402971","hg19,16:g.87436577C>A, hg38,16:g.87402971C>A",0.290,,,0.0000079612763518,0.0000318390219052,,,Uncertain significance,not specified,1,3542644
96,85,G,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
97,86,H,D,,,,,,,,,,,,,ClinVar,,,"hg19,16:87436581-87436581, hg38,16:87402975-87402975","hg19,16:g.87436581C>G, hg38,16:g.87402975C>G",0.241,,,0.0000278613618634,0.0000318430773150,,,Uncertain significance,not specified,1,2553606
98,87,S,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 87-93, ELM",,,,,,,,,,,,,,,,,
99,88,M,T,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 88-94, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 87-93, ELM",,ClinVar,,,"hg19,16:87436588-87436588, hg38,16:87402982-87402982","hg19,16:g.87436588T>C, hg38,16:g.87402982T>C",0.502,,,,,,,Uncertain significance,not specified,1,3870024
100,89,V,F,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 88-94, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 87-93, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,16:87436590-87436590, hg38,16:87402984-87402984","hg19,16:g.87436590G>T, hg38,16:g.87402984G>T",0.578,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,
101,90,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 90-95, ELM|SH3 domain ligands (LIG_SH3_3), 88-94, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 87-93, ELM",,,,,,,,,,,,,,,,,
102,91,V,I,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_2), 91-97, ELM|Cks1 ligand (DOC_CKS1_1), 91-96, ELM|WW domain ligands (DOC_WW_Pin1_4), 90-95, ELM|SH3 domain ligands (LIG_SH3_3), 88-94, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 87-93, ELM",,"COSMIC,ClinVar",,,"hg19,16:87436596-87436596, hg38,16:87402990-87402990","hg19,16:g.87436596G>A, hg38,16:g.87402990G>A",0.172,endometrium,"carcinoma, endometrioid_carcinoma",0.0000875329243159,0.0000636942675159,,,Uncertain significance,not specified,1,2406999
103,92,S,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_2), 91-97, ELM|Cks1 ligand (DOC_CKS1_1), 91-96, ELM|WW domain ligands (DOC_WW_Pin1_4), 90-95, ELM|SH3 domain ligands (LIG_SH3_3), 88-94, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 87-93, ELM",,,,,,,,,,,,,,,,,
104,93,T,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_2), 91-97, ELM|Cks1 ligand (DOC_CKS1_1), 91-96, ELM|WW domain ligands (DOC_WW_Pin1_4), 90-95, ELM|SH3 domain ligands (LIG_SH3_3), 88-94, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 87-93, ELM",,,,,,,,,,,,,,,,,
105,94,P,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_2), 91-97, ELM|Cks1 ligand (DOC_CKS1_1), 91-96, ELM|WW domain ligands (DOC_WW_Pin1_4), 90-95, ELM|SH3 domain ligands (LIG_SH3_3), 88-94, ELM",,,,,,,,,,,,,,,,,
106,95,I,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_2), 91-97, ELM|Cks1 ligand (DOC_CKS1_1), 91-96, ELM|WW domain ligands (DOC_WW_Pin1_4), 90-95, ELM",,,,,,,,,,,,,,,,,
107,96,S,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_2), 91-97, ELM|Cks1 ligand (DOC_CKS1_1), 91-96, ELM",,,,,,,,,,,,,,,,,
108,97,E,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_2), 91-97, ELM",,,,,,,,,,,,,,,,,
109,98,V,A,,,,,,,,,,,,,cBioPortal,lihc_amc_prv,Hepatocellular Carcinoma,"hg19,16:87436618-87436618","hg19,16:g.87436618T>C",0.265,,,0.0000000000000000,,,,,,,
110,98,V,L,,,,,,,,,,,,,ClinVar,,,"hg19,16:87436617-87436617, hg38,16:87403011-87403011","hg19,16:g.87436617G>T, hg38,16:g.87403011G>T",0.047,,,0.0000039774399605,,,,Uncertain significance,not specified,1,3542643
111,98,V,M,,,,,,,,,,,,,COSMIC,,,"hg38,16:87403011-87403011","hg38,16:g.87403011G>A",0.395,"stomach, gastroesophageal_junction",carcinoid-endocrine_tumour,,,,,,,,
112,99,Y,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
113,100,E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
114,101,S,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
115,102,E,K,,,,,,,,,,,,,ClinVar,,,"hg19,16:87436629-87436629, hg38,16:87403023-87403023","hg19,16:g.87436629G>A, hg38,16:g.87403023G>A",0.315,,,,,,,Uncertain significance,not specified,1,3122723
116,103,K,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
117,104,D,H,,,,,,,,,,,,,cBioPortal,lung_smc_2016,Lung,"hg19,16:87436635-87436635","hg19,16:g.87436635G>C",0.654,,,,,,,,,,
118,105,E,K,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436638-87436638","hg19,16:g.87436638G>A",0.220,,,,,,,,,,
119,106,D,G,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM",,cBioPortal,"metastatic_solid_tumors_mich_2017, pancan_pdmr_2025",Mixed Cancer Types,"hg19,16:87436642-87436642","hg19,16:g.87436642A>G",0.866,,,0.0000278396436526,,,,,,,
120,107,G,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM",,,,,,,,,,,,,,,,,
121,108,F,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM",,,,,,,,,,,,,,,,,
122,109,L,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM",,,,,,,,,,,,,,,,,
123,110,Y,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM",,,,,,,,,,,,,,,,,
124,111,M,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM",,cBioPortal,"ccle_broad_2019, coad_cptac_2019","Colon Adenocarcinoma, Mixed Cancer Types","hg19,16:87436656-87436656","hg19,16:g.87436656A>G",0.274,,,0.0000039771235851,,,,,,,
125,112,V,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM",,,,,,,,,,,,,,,,,
126,113,Y,C,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 113-116, ELM",,"cBioPortal,COSMIC","acbc_mskcc_2015, acc_2019, bcc_unige_2016, kich_tcga","Adenoid Cystic Breast Cancer, Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Chromophobe Renal Cell Carcinoma","hg19,16:87436663-87436663, hg38,16:87403057-87403057","hg19,16:g.87436663A>G, hg38,16:g.87403057A>G",0.771,"breast, liver, oesophagus, middle_third, prostate, skin, skin, face, skin, foot","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",0.0012870707888934,,,,,,,
127,114,A,T,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 113-116, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436665-87436665","hg19,16:g.87436665G>A",0.411,,,,,,,,,,
128,114,A,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 105-114, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 106-114, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 113-116, ELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,16:87436666-87436666","hg19,16:g.87436666C>T",0.436,,,,,,,,,,
129,115,S,F,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 113-116, ELM",,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,16:87436669-87436670","hg19,16:g.87436669_87436670delinsTT",,,,,,,,,,,
130,116,Q,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 113-116, ELM",,,,,,,,,,,,,,,,,
131,117,E,V,,,,,,,,,,,,,COSMIC,,,"hg38,16:87403069-87403069","hg38,16:g.87403069A>T",0.640,lung,"carcinoma, adenocarcinoma",0.0000000000000000,,,,,,,
132,118,T,A,,,,,,,,,,,,,cBioPortal,"pancan_pdmr_2025, pptc_2019, prad_msk_mdanderson_2023","Mixed Cancer Types, Prostate","hg19,16:87436677-87436677","hg19,16:g.87436677A>G",0.435,,,0.0006486451424587,,,,,,,
133,118,T,M,,,,,,,,,,,,,COSMIC,,,"hg38,16:87403072-87403072","hg38,16:g.87403072C>T",0.370,"central_nervous_system, brain",primitive_neuroectodermal_tumour-medulloblastoma,0.0000363134577674,,,,,,,
134,119,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
135,120,G,E,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,cBioPortal,cscc_ranson_2022,Cutaneous Squamous Cell Carcinoma,"hg19,16:87403078-87403078","hg19,16:g.87403078G>A",,,,,,,,,,,
136,120,G,R,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,"cBioPortal,COSMIC",stad_utokyo,Stomach Adenocarcinoma,"hg19,16:87436683-87436683, hg38,16:87403077-87403077","hg19,16:g.87436683G>A, hg38,16:g.87403077G>A",0.705,stomach,"carcinoma, carcinoma, diffuse_adenocarcinoma",0.0000040617714198,0.0000318511912346,,,,,,
137,120,G,V,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,COSMIC,,,"hg38,16:87403078-87403078","hg38,16:g.87403078G>T",0.678,liver,"other, neoplasm",,,,,,,,
138,121,M,,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,,,,,,,,,,,,,,,,
139,122,K,,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,,,,,,,,,,,,,,,,
140,123,L,S,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:87436693-87436693, hg38,16:87403087-87403087","hg19,16:g.87436693T>C, hg38,16:g.87403087T>C",0.044,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,
141,123,L,V,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:87436692-87436692","hg19,16:g.87436692T>G",0.025,,,,,,,,,,
142,124,S,,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,,,,,,,,,,,,,,,,
143,125,V,A,,,,,,,,,,,"PDZ domain ligands (LIG_PDZ_Class_2), 120-125, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436699-87436699","hg19,16:g.87436699T>C",0.035,,,0.0000393528640140,0.0000637429882713,,,,,,
